Viracta Therapeutics, Inc.
VIRX · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$10,553 | -$9,830 | -$9,141 | -$13,765 |
| Dep. & Amort. | -$575 | $96 | $110 | $123 |
| Deferred Tax | $0 | $0 | $0 | -$1,950 |
| Stock-Based Comp. | $1,251 | $1,376 | $1,837 | $1,784 |
| Change in WC | $1,564 | -$1,246 | -$318 | $2,306 |
| Other Non-Cash | $1,220 | -$223 | $1,750 | $1,475 |
| Operating Cash Flow | -$7,093 | -$9,827 | -$7,849 | -$10,027 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | -$180 |
| Inv. Purchases | -$3,490 | -$3,586 | -$6,057 | -$7,480 |
| Inv. Sales/Matur. | $11,650 | $15,289 | $20,249 | $16,750 |
| Other Inv. Act. | $0 | $0 | $14,192 | $9 |
| Investing Cash Flow | $8,160 | $11,703 | $14,192 | $9,270 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,921 | -$1 | -$6,678 | $0 |
| Stock Issued | -$44 | $44 | $80 | $172 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $44 | $0 | $46 |
| Financing Cash Flow | -$1,921 | $43 | -$6,598 | $218 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$854 | $1,919 | -$255 | -$539 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,981 | $12,062 | $12,317 | $12,856 |
| End Cash | $13,127 | $13,981 | $12,062 | $12,317 |
| Free Cash Flow | -$7,093 | -$9,827 | -$7,849 | -$10,027 |